Evaluation of SOMAVAC 100 Sustained Vacuum System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-01

Study Completion Date

2022-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to compare the effectiveness of the Somavac 100 Sustained Vacuum System versus manual section bulbs after immediate breast reconstruction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis

NCT05665894

Breast Haematoma Breast Cancer Breast Diseases

COMPLETED

Shave Margins in Breast Conservation Therapy

NCT02462200

Breast Cancer Cancer of Breast Cancer of the Breast

TERMINATED PHASE2

A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery

NCT07071402

Breast Cancer (Early Breast Cancer)

RECRUITING NA

Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®

NCT05825482

Breast Cancer

RECRUITING NA

Tumor: Breast Ratio Study

NCT02216136

Breast Cancer LCIS DCIS

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will undergo a screening that includes medical history review. Once screening is complete, participants will undergo immediate breast reconstruction per the surgeon's typical protocol. Surgeon will place up to two (2) drain(s) per breast as customary without changing their technique at the end of the surgical procedure. SOMAVAC® 100 Sustained Vacuum System will be attached to the end of the drain(s) on one side of the subject and standard of care manual suction bulbs attached to the other side. Subjects will return to the clinic every 72 hours for visits for the first 1 to 2 weeks, until the drain drops below 25mL, or as instructed by the physician. Each visit will take about 30 minutes. Subjects will have routine phone calls with the clinic to provide their drain output information to help determine when the drains should be removed. This is a study where the standard techniques of closed suction drainage are used for the removal of fluid from a surgical site. Hence, an increased risk related to post-operative care is not anticipated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SOMAVAC 100 Sustained Vacuum System

New sustained vacuum system

SOMAVAC 100 Sustained Vacuum System

Intervention Type DEVICE

Evaluate performance of sustained vacuum system compared to manual suction bulbs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SOMAVAC 100 Sustained Vacuum System

Evaluate performance of sustained vacuum system compared to manual suction bulbs

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 21 years or older; undergoing immediate pre-pectoral breast reconstruction after mastectomy (bilateral) with tissue expanders or implant
* Capable of providing informed consent
* Willingness to follow all study requirements including agreeing to attend all required follow-up visits and signs the informed consent.

Exclusion Criteria

* Reconstruction is not post-mastectomy
* Pregnant or lactating females
* Patients needing more than 2 drains per breast
* Patients on steroids or other immune modulators known to impact healing
* Patients who are likely to not complete the study
* Patient who, in the opinion of the investigator, are unlikely to comply with the protocol
* Patients who have participated in this trial previously and who were withdrawn
* Patients with known allergies to contacting materials (i.e. latex, metal, etc.)
* Patients who received neoadjuvant chemotherapy or radiotherapy within the last 6 months
* Has any medical condition such as obesity (BMI\>40), uncontrolled diabetes (HbA1c\>7%) and/or immunosuppression.

Minimum Eligible Age

21 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No